Information Library
Oncology
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Mapping the Future in Oncology Drug Development
August 27, 2010
Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development -
Biomarkers as an Approach to Improving Productivity in Oncology Drug Development
August 19, 2010
Richard Gaynor, MD of Eli Lilly presents Biomarkers as an Approach to Improving Productivity in Oncology Drug Development -
Regulatory Opportunities
August 13, 2010
John Smyth, MD of the University of Edinburgh presents on Regulatory Opportunities. -
New Pilot Examples Exploring these Novel Approaches
August 13, 2010
King Jolly, PharmD of Quintiles discusses New Pilot Examples Exploring these Novel Approaches -
New Pilot Examples Exploring these Novel Approaches
August 13, 2010
Daniel Haller, MD of the University of Pennsylvania Presents on New Pilot Examples Exploring these Novel Approaches. -
Improvements in Trial Design
August 13, 2010
Gail Eckhardt, MD University of Colorado Cancer Center presents Improvements in Trial Design -
Welcome and Introductory Remarks
August 13, 2010
Welcome and Introductory Remarks at Quintiles Ancillary Event at ASCO 2010 -
NOBEL LAUREATE JOINS QUINTILES SCIENTIFIC ADVISORY BOARD
August 11, 2010 – Quintiles' announces the addition of Aaron Ciechanover, M.D., D.Sc., recipient of the Nobel Prize in Chemistry in 2004, to its Translational Research and Development Scientific Advisory Board.
-
The Evolution of Oncologic Drug Development
July 8, 2010
Despite a doubling in the number of candidates in the cancer drug pipeline from 1990 through 2006, the overall US approval rate for cancer drugs -
Clinical Trials: Race to Study Launch & Speed to Finish
July 2, 2010
Chris Cabell's presentation at DIA US 2010 - Clinical Trials:Race to Study Launch and Speed to Finish
